Market Overview

St. Jude's Abbott Merger On Track For Q4


St. Jude Medical, Inc. (NYSE: STJ) expects to complete its merger with Abbott Laboratories (NYSE: ABT) by yearend 2016. Argus’s David Toung maintained a Hold rating on St. Jude, citing the pending acquisition.

St. Jude reported its Q2 adjusted EPS at $1.06, up from $1.03 a year earlier. GAAP net income came in at $238 million, or $$0.83 per share, representing a y/y decline from $290 million, or $1.02 per share. The company posted net sales of $1.562 billion, up 11 percent. EBIT margin came in at 23.0 percent, down 130bps from 2Q15.

Pending Merger

St. Jude remains on track to completing its merger with Abbott by the end of Q4, analyst Toung mentioned. The deal is valued at about $85 per share of the company, to be paid in cash and Abbott stock. Due to the pending deal, St. Jude has withdrawn its financial guidance for 2016.

Standalone Assumptions

The adjusted EPS estimates for St. Jude on a standalone basis is $4.00 for 2016 and $4.30 for 2017.

“STJ shares are trading at 18.0-times our 2017 EPS estimate, slightly below the average multiple of 18.7 for our coverage universe of med-tech stocks,” Toung stated. He added that the Hold rating has been maintained due to the pending merger.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for STJ

Jul 2016WedbushDowngradesOutperformNeutral
Jul 2016Leerink SwannDowngradesOutperformMarket Perform
May 2016BarclaysDowngradesOverweightEqual-Weight

View More Analyst Ratings for STJ
View the Latest Analyst Ratings


Related Articles (STJ)

View Comments and Join the Discussion!

Posted-In: Argus David ToungAnalyst Color Reiteration Analyst Ratings

Latest Ratings

AYLANoble Capital MarketsInitiates Coverage On29.0
SHOPSusquehannaInitiates Coverage On950.0
SICraig-HallumInitiates Coverage On50.0
WORKStephens & Co.Downgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at